Paper189658
Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients.
Barndt R and 3 others. Ann Intern Med, 1977. Cited by 205 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients. Papers, record 189658. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/189658
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arteriosclerosis | Major topic |
| Femoral Artery | Major topic |
| Hyperlipidemias | Major topic |
| Adult | |
| Aged | |
| Blood Pressure | |
| Cholesterol | |
| Female | |
| Humans | |
| Lipoproteins, LDL | |
| Lipoproteins, VLDL | |
| Male | |
| Middle Aged | |
| Radiography | |
| Remission, Spontaneous | |
| Triglycerides |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 205 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32827219 | Reduction in saturated fat intake for cardiovascular disease. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32827219 | PubMed |
| 32476140 | Effects of total fat intake on body fatness in adults. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32476140 | PubMed |
| 32428300 | Reduction in saturated fat intake for cardiovascular disease. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32428300 | PubMed |
| 26250104 | Effects of total fat intake on body weight. | Cochrane Database Syst Rev | 2015 | https://conductscience.org/library/papers/26250104 | PubMed |
| 22592684 | Reduced or modified dietary fat for preventing cardiovascular disease. | Cochrane Database Syst Rev | 2012 | https://conductscience.org/library/papers/22592684 | PubMed |
| 21735388 | Reduced or modified dietary fat for preventing cardiovascular disease. | Cochrane Database Syst Rev | 2011 | https://conductscience.org/library/papers/21735388 | PubMed |
| 21279150 | Hyperlipidemia: time to treat? | Can Fam Physician | 1985 | https://conductscience.org/library/papers/21279150 | PubMed |
| 20919379 | Can drug therapy alter the natural course of peripheral vascular disease?: a review. | Proc R Soc Med | 1977 | https://conductscience.org/library/papers/20919379 | PubMed |
| 8212682 | Atherosclerosis--reversal with therapy. | West J Med | 1993 | https://conductscience.org/library/papers/8212682 | PubMed |
| 7426147 | Assessment of long-term plasma exchange for familial hypercholesterolaemia. | Br Heart J | 1980 | https://conductscience.org/library/papers/7426147 | PubMed |
| 7000278 | Non-surgical management of peripheral vascular disease: a review. | Br Med J | 1980 | https://conductscience.org/library/papers/7000278 | PubMed |
| 6996783 | Dietary prevention of ischaemic heart disease--a policy for the '80s. | Br Med J | 1980 | https://conductscience.org/library/papers/6996783 | PubMed |
| 6656175 | [Extracardiac atherosclerosis in patients with familial hypercholesterolemia]. | Klin Wochenschr | 1983 | https://conductscience.org/library/papers/6656175 | PubMed |
| 6215241 | Current therapy for intermittent claudication. | Drugs | 1982 | https://conductscience.org/library/papers/6215241 | PubMed |
| 6122754 | [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)]. | Klin Wochenschr | 1982 | https://conductscience.org/library/papers/6122754 | PubMed |
| 3668899 | Reduction of blood cholesterol levels in the population: can it be done? | J R Coll Gen Pract | 1986 | https://conductscience.org/library/papers/3668899 | PubMed |
| 3063503 | Interrelationship of hypertension, plasma lipids and atherosclerosis. | Drugs | 1988 | https://conductscience.org/library/papers/3063503 | PubMed |
| 2044639 | Indications for lipid-lowering drugs. | Eur J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/2044639 | PubMed |
| 871733 | Regression of atheroma. | Br Med J | 1977 | https://conductscience.org/library/papers/871733 | PubMed |
| 215767 | Hypothesis into theory--the development of aetiological concepts of ischaemic heart disease: a review. | J R Soc Med | 1978 | https://conductscience.org/library/papers/215767 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/189658
GET https://conductscience.org/api/papers/v1/189658/cited_by?page=2